Stoke Therapeutics, Inc. (STOK) Insider Trading -- Recent Executive & Director Transactions

12 insiders reported 137 Form 4 transactions for Stoke Therapeutics, Inc. (STOK) over the past 18 months (most recent 2026-09-03). Recent activity: Ticho Barry (CHIEF MEDICAL OFFICER) Sell 3,945 shares, Ticho Barry (CHIEF MEDICAL OFFICER) Sell 1,600 shares, Kaye Edward M. MD (Director) Buy 26,250 shares, Ticho Barry (CHIEF MEDICAL OFFICER) Buy 10,000 shares, Allan Jonathan (GENERAL COUNSEL & CORP SEC) Buy 6,000 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-09-03Ticho BarryCHIEF MEDICAL OFFICERSell3,945$120,370
2026-09-03Ticho BarryCHIEF MEDICAL OFFICERSell1,600$49,691
2026-08-18Kaye Edward M. MDDirectorBuy26,250$0
2026-08-18Ticho BarryCHIEF MEDICAL OFFICERBuy10,000$0
2026-08-18Allan JonathanGENERAL COUNSEL & CORP SECBuy6,000$0
2026-08-18Kaye Edward M. MDDirectorSell11,930$381,846
2026-08-18Ticho BarryCHIEF MEDICAL OFFICERSell4,525$144,833
2026-08-18Allan JonathanGENERAL COUNSEL & CORP SECSell2,716$86,932
2026-08-18Kaye Edward M. MDDirectorSell637$20,682
2026-08-18Ticho BarryCHIEF MEDICAL OFFICERSell242$7,857
2026-08-18Allan JonathanGENERAL COUNSEL & CORP SECSell145$4,708
2026-08-05Ticho BarryCHIEF MEDICAL OFFICERSell5,907$171,008
2026-08-05Ticho BarryCHIEF MEDICAL OFFICERSell1,269$37,377
2026-07-06Ticho BarryCHIEF MEDICAL OFFICERSell6,728$219,434
2026-07-06Ticho BarryCHIEF MEDICAL OFFICERSell500$16,634
2026-06-18Allan JonathanGENERAL COUNSEL & CORP SECSell1,457$43,637
2026-06-03Ticho BarryCHIEF MEDICAL OFFICERSell1,795$54,891
2026-05-05Ticho BarryCHIEF MEDICAL OFFICERSell2,243$73,548
2026-04-03Ticho BarryCHIEF MEDICAL OFFICERSell1,838$60,029
2026-03-24Allan JonathanGENERAL COUNSEL & CORP SECSell8,692$292,399
2026-03-24Allan JonathanGENERAL COUNSEL & CORP SECSell601$20,680
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell3,577$117,111
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell2,587$86,354
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell6,100$190,808
2026-03-19Ticho BarryCHIEF MEDICAL OFFICERSell483$15,355

来源:SEC Form 4 申报文件 · 截至 2026-09-03